
Novo Nordisk, Eli Lilly and the GLP-1 economy
Unhedged
00:00
Intro
This chapter explores the projected market growth and transformative effects of GLP-1 weight loss drugs on obesity treatment. It discusses the skepticism surrounding the hype, their implications for health systems and insurance, as well as current usage and challenges such as side effects.
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.